ATE170559T1 - Behandlung der hiv-assoziierten immun- thrombopenie purpura - Google Patents

Behandlung der hiv-assoziierten immun- thrombopenie purpura

Info

Publication number
ATE170559T1
ATE170559T1 AT92912556T AT92912556T ATE170559T1 AT E170559 T1 ATE170559 T1 AT E170559T1 AT 92912556 T AT92912556 T AT 92912556T AT 92912556 T AT92912556 T AT 92912556T AT E170559 T1 ATE170559 T1 AT E170559T1
Authority
AT
Austria
Prior art keywords
hiv
treatment
associated immune
thrombopenia purpura
purpura
Prior art date
Application number
AT92912556T
Other languages
English (en)
Inventor
Arthur J Ammann
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE170559T1 publication Critical patent/ATE170559T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Tires In General (AREA)
AT92912556T 1991-05-31 1992-04-15 Behandlung der hiv-assoziierten immun- thrombopenie purpura ATE170559T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70900691A 1991-05-31 1991-05-31

Publications (1)

Publication Number Publication Date
ATE170559T1 true ATE170559T1 (de) 1998-09-15

Family

ID=24848090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912556T ATE170559T1 (de) 1991-05-31 1992-04-15 Behandlung der hiv-assoziierten immun- thrombopenie purpura

Country Status (9)

Country Link
US (1) US5605689A (de)
EP (1) EP0636173B1 (de)
JP (1) JPH06508133A (de)
AT (1) ATE170559T1 (de)
AU (1) AU651228B2 (de)
CA (1) CA2108580A1 (de)
DE (1) DE69226877T2 (de)
DK (1) DK0636173T3 (de)
WO (1) WO1992021755A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
CA2433877C (en) * 2001-01-17 2014-11-18 Aptevo Research And Development Llc Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
AU2008200400B2 (en) * 2001-01-17 2012-06-07 Aptevo Research And Development Llc Binding domain-immunoglobulin fusion proteins
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
AU2002363465A1 (en) * 2001-10-25 2003-05-19 The Government Of The United States Of America As Represented By The Secretary Of Health And Human S Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
US6707888B1 (en) * 2002-05-06 2004-03-16 Sprint Communications Company, L.P. Location evaluation for callers that place emergency telephone calls over packet networks
TWI353991B (en) * 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US7348004B2 (en) * 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
AU2004238263A1 (en) * 2003-05-06 2004-11-25 Syntonix Pharmaceuticals, Inc. Inhibition of drug binding to serum albumin
PT1624891E (pt) * 2003-05-06 2010-01-05 Syntonix Pharmaceuticals Inc Proteínas quiméricas de factor de coagulação-fc destinadas ao tratamento da hemofilia
US7754209B2 (en) 2003-07-26 2010-07-13 Trubion Pharmaceuticals Binding constructs and methods for use thereof
ES2460517T3 (es) 2005-07-25 2014-05-13 Emergent Product Development Seattle, Llc Reducción de células b mediante el uso de moléculas de unión específica a cd37 y de unión específica a cd20
WO2007035870A2 (en) 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
EP2418223A3 (de) 2006-06-12 2013-01-16 Emergent Product Development Seattle, LLC Einkettige, multivalente Bindungsproteine mit Effektorfunktion
EP3485742B1 (de) * 2006-11-29 2021-09-01 Prolacta Bioscience, Inc. Muttermilchzusammensetzungen sowie verfahren zur herstellung und verwendung davon
WO2008073888A2 (en) 2006-12-08 2008-06-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
PT2132228E (pt) 2008-04-11 2011-10-11 Emergent Product Dev Seattle Imunoterapia de cd37 e sua combinação com um quimioterápico bifuncional
US8927027B2 (en) 2008-12-02 2015-01-06 Prolacta Bioscience Human milk permeate compositions and methods of making and using same
ES2655019T3 (es) 2011-08-03 2018-02-16 Prolacta Bioscience, Inc. Microfiltración de leche humana para reducir la contaminación bacteriana
BR112015022059B1 (pt) 2013-03-13 2021-06-08 Prolacta Bioscience, Inc composições de nata de leite humano pasteurizada com alto teor de gordura e método para fabricar uma composição de nata de leite humano pasteurizada com alto teor de gordura
EA037906B1 (ru) 2013-03-15 2021-06-04 Биовератив Терапьютикс Инк. Препараты полипептида фактора ix
MX2018003292A (es) 2015-09-21 2018-08-01 Aptevo Res & Development Llc Polipéptidos de unión a cd3.
AU2016381834B2 (en) 2015-12-30 2021-09-23 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
AU2019205942B2 (en) 2018-01-05 2025-05-15 Platelet Biogenesis, Inc. Compositions and methods for producing megakaryocytes
US12403161B2 (en) 2018-06-29 2025-09-02 Stellular Bio, Inc. Compositions for drug delivery and methods of use thereof
KR20220066904A (ko) 2019-09-24 2022-05-24 프롤랙타 바이오사이언스, 인코포레이티드 염증 및 면역 질환의 치료용 조성물 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
PT88641B (pt) * 1987-10-02 1993-04-30 Genentech Inc Metodo para a preparacao de uma variante de adesao
ZA89430B (en) * 1988-01-22 1989-10-25 Gen Hospital Corp Cloned genes encoding ig-cd4 fusion proteins and the use thereof
EP0423198B1 (de) * 1988-07-06 1996-05-08 VERIGEN, INC. (a Corporation of Delaware) Gegen hiv 1 gp48 spezifische antikörper
IL91386A0 (en) * 1988-08-24 1990-04-29 Boehringer Ingelheim Kg Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it
DE69010523D1 (de) * 1989-03-03 1994-08-18 Microgenesys Inc Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
AU641645B2 (en) * 1989-04-03 1993-09-30 Genetics Institute Inc. Megakaryocyte growth promoting activity
EP0394827A1 (de) * 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimärische CD4-Immunoglobulin-Polypeptide

Also Published As

Publication number Publication date
CA2108580A1 (en) 1992-12-01
EP0636173B1 (de) 1998-09-02
WO1992021755A1 (en) 1992-12-10
EP0636173A1 (de) 1995-02-01
DK0636173T3 (da) 1999-05-31
AU2003192A (en) 1993-01-08
DE69226877T2 (de) 1999-03-11
DE69226877D1 (de) 1998-10-08
AU651228B2 (en) 1994-07-14
JPH06508133A (ja) 1994-09-14
US5605689A (en) 1997-02-25

Similar Documents

Publication Publication Date Title
ATE170559T1 (de) Behandlung der hiv-assoziierten immun- thrombopenie purpura
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DK0662827T3 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
GB2128088B (en) Oral mopidamol preparations
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
DE69837324D1 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
DE69331758D1 (de) Fibrinogen-bildungsprotein
ATE100714T1 (de) Arzneimittel (calcitoningen verwandte peptide) zur behandlung erektiler dysfunktionen.
GR1002091B (en) A process for providing a composition comprising an antidiarrheal and an antiflatulent
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
DK241287D0 (da) Anvendelse af glutamin til fremstilling af et laegemiddel til behandling af kataboliske forstyrrelser
ATE9437T1 (de) Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen.
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
ATE251631T1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
DK561589D0 (da) Flydende oralt farmaceutisk praeparat
NO892266D0 (no) Amblyommin, et nytt virkemiddel for antikoagulasjonsterapien.
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
ATE44751T1 (de) Zusammensetzungen zum behandeln von ischaemie im gehirn.
PT77577B (de) 5-phenoxybenzoesaeurederivate von pentiten verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit herbizider wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee